123 related articles for article (PubMed ID: 21688846)
1. New nitric oxide or hydrogen sulfide releasing aspirins.
Lazzarato L; Chegaev K; Marini E; Rolando B; Borretto E; Guglielmo S; Joseph S; Di Stilo A; Fruttero R; Gasco A
J Med Chem; 2011 Aug; 54(15):5478-84. PubMed ID: 21688846
[TBL] [Abstract][Full Text] [Related]
2. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins.
Lazzarato L; Donnola M; Rolando B; Chegaev K; Marini E; Cena C; Di Stilo A; Fruttero R; Biondi S; Ongini E; Gasco A
J Med Chem; 2009 Aug; 52(16):5058-68. PubMed ID: 20560642
[TBL] [Abstract][Full Text] [Related]
3. Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin.
Cena C; Lolli ML; Lazzarato L; Guaita E; Morini G; Coruzzi G; McElroy SP; Megson IL; Fruttero R; Gasco A
J Med Chem; 2003 Feb; 46(5):747-54. PubMed ID: 12593655
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble nitric-oxide-releasing acetylsalicylic acid (ASA) prodrugs.
Rolando B; Lazzarato L; Donnola M; Marini E; Joseph S; Morini G; Pozzoli C; Fruttero R; Gasco A
ChemMedChem; 2013 Jul; 8(7):1199-209. PubMed ID: 23754790
[TBL] [Abstract][Full Text] [Related]
5. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
Chattopadhyay M; Kodela R; Olson KR; Kashfi K
Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
[TBL] [Abstract][Full Text] [Related]
6. Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.
Lazzarato L; Donnola M; Rolando B; Marini E; Cena C; Coruzzi G; Guaita E; Morini G; Fruttero R; Gasco A; Biondi S; Ongini E
J Med Chem; 2008 Mar; 51(6):1894-903. PubMed ID: 18293898
[TBL] [Abstract][Full Text] [Related]
7. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.
Lazzarato L; Cena C; Rolando B; Marini E; Lolli ML; Guglielmo S; Guaita E; Morini G; Coruzzi G; Fruttero R; Gasco A
Bioorg Med Chem; 2011 Oct; 19(19):5852-60. PubMed ID: 21906954
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.
Jones M; Inkielewicz I; Medina C; Santos-Martinez MJ; Radomski A; Radomski MW; Lally MN; Moriarty LM; Gaynor J; Carolan CG; Khan D; O'Byrne P; Harmon S; Holland V; Clancy JM; Gilmer JF
J Med Chem; 2009 Nov; 52(21):6588-98. PubMed ID: 19821574
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
10. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
[TBL] [Abstract][Full Text] [Related]
11. Nitrosyl-cobinamide, a new and direct nitric oxide releasing drug effective in vivo.
Broderick KE; Alvarez L; Balasubramanian M; Belke DD; Makino A; Chan A; Woods VL; Dillmann WH; Sharma VS; Pilz RB; Bigby TD; Boss GR
Exp Biol Med (Maywood); 2007 Dec; 232(11):1432-40. PubMed ID: 18040067
[TBL] [Abstract][Full Text] [Related]
12. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
13. 6-Methylnitroarachidonate: a novel esterified nitroalkene that potently inhibits platelet aggregation and exerts cGMP-mediated vascular relaxation.
Blanco F; Ferreira AM; López GV; Bonilla L; González M; Cerecetto H; Trostchansky A; Rubbo H
Free Radic Biol Med; 2011 Feb; 50(3):411-8. PubMed ID: 21145389
[TBL] [Abstract][Full Text] [Related]
14. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.
Kodela R; Chattopadhyay M; Velázquez-Martínez CA; Kashfi K
Biochem Pharmacol; 2015 Dec; 98(4):564-72. PubMed ID: 26394025
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: synthesis, biological evaluation and nitric oxide release studies.
Chowdhury MA; Abdellatif KR; Dong Y; Yu G; Huang Z; Rahman M; Das D; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2010 Feb; 20(4):1324-9. PubMed ID: 20097072
[TBL] [Abstract][Full Text] [Related]
17. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
[TBL] [Abstract][Full Text] [Related]
18. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
19. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
